Nuvectis Pharma (NVCT) PEG Ratio

Price: $9.915
Market Cap: $231.93M
Avg Volume: 140.58K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.22
52W Range: $4.44-11.8
Website: Nuvectis Pharma

PEG Ratio Summary

  • Nuvectis Pharma's trailing twelve month (TTM) PEG ratio is -10.09.
  • Nuvectis Pharma's annual PEG ratio as of today is 0.22.
  • Nuvectis Pharma's quarterly PEG ratio is -0.07.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess Nuvectis Pharma's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -4.87
    • Quarterly: -3.70
    • TTM: -8.93
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 9.53
    • Quarterly: 9.53
    • TTM: 17.47
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -7.56
    • Quarterly: -37.56
    • TTM: -13.85

These metrics provide insights into Nuvectis Pharma's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

-10.09

Annual PEG Ratio

0.22

Quarterly PEG Ratio

-0.07

Nuvectis Pharma Historical PEG Ratio

1.831.831.191.190.540.54-0.11-0.11PEG Ratio0.221.73-0.11-0.000.0020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Historical P/E Ratio

0.000.00-1000.00-1000.00-2000.00-2000.00-3000.00-3000.00-4000.00-4000.00-5000.00-5000.00P/E Ratio-4.87-5.83-5.05-3.21-4133.2820212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Historical P/S Ratio

800.00800.00600.00600.00400.00400.00200.00200.000.000.00P/S Ratio0.000.00637.130.000.0020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Historical P/B Ratio

1000.001000.000.000.00-1000.00-1000.00-2000.00-2000.00-3000.00-3000.00-4000.00-4000.00-5000.00-5000.00P/B Ratio9.5310.636.68-3.75-4133.2820212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Historical P/CF Ratio

2000.002000.001600.001600.001200.001200.00800.00800.00400.00400.000.000.00-400.00-400.00P/CF Ratio-7.56-8.13-7.00-4.351722.2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

Nuvectis Pharma Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2024 0.22 -4.87 0.00 9.53 -7.56
2023 1.73 -5.83 0.00 10.63 -8.13
2022 -0.11 -5.05 637.13 6.68 -7.00
2021 0.00 -3.21 0.00 -3.75 -4.35
2020 0.00 -4133.28 0.00 -4133.28 1722.20

Related Metrics

Explore detailed financial metrics and analysis for NVCT.